I only give one advice, do not let others do your thinking for you.

Joined February 2011
254 Photos and videos
Short squeeze inbound! $SINCH #StockTwits #StockMarketwin
226
Mr.Charles retweeted
14 Oct 2025
$CLPT PRISM Neuro Laser is going to be huge. Top and center even at the conference. Clinical Laserthermia Systems $CLS.b partnership is really special in terms of effectiveness and features, best in class.
#ClearPoint Neuro has grown & evolved so much over these past several years. We have so much more planned looking ahead & now with the right team, resources, & partnerships in place. That is why we call this next chapter for us: Fast. Forward. #2025CNS #CLPT #DBS
1
5
45
6,241
Mr.Charles retweeted
#ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles at Booth 545 - Read More Here: loom.ly/Fv4xNnk #2025CNS #CLPT #LITT #LaserTherapy #Glioblastoma #NeuroOncology #MedTech
10
53
1,709
Mr.Charles retweeted
$CLS.b Good to see the new 1.5T approval. Going full neuro was the right and obvious move. $CLPT.
4
43
5,151
A Milestone Moment for Clinical Laserthermia Systems & ClearPoint Neuro Clinical Laserthermia Systems ($CLS.B) & ClearPoint Neuro ($CLPT) have submitted an FDA application to expand ClearPoint Prism™ to 1.5T MRI guidance. This is a pivotal step for neuro laser therapy. #MedTech
1
2
9
508
This submission isn’t just about one product—it’s about transforming neurosurgery. Approval could accelerate adoption, drive revenue, and position $CLS.B & $CLPT as leaders in a booming field. Investors, take note! #HealthcareInnovation
1
2
10
666
HUGE news for $CLS.B! New updated clinical guidelines now officially recommend Laser Interstitial Thermal Therapy (LITT) for patients with metastatic brain tumors & radiation necrosis. This is not just good — it's transformational. Let’s break it down. 👇
1
2
17
2,067
Radiation necrosis and metastatic brain tumors are growing clinical challenges. There’s high unmet need. CLS’s and Clearpoint´s LITT platform just became part of the solution — by guideline. That’s huge!
1
7
236
This is the kind of catalyst that shifts sentiment, boosts revenue potential, and builds long-term strategic value. #CLS #LITT #NeuroOncology #Medtech $CLS.B $CLPT #cancer
2
12
851
Mr.Charles retweeted
Stoked to see what changes Peter can bring at $CLS.b!
Added $CLS.b. First set of open market insider buys for the company in a long, long time. Time to go to work on the back of renewed focus and inflection. news.cision.com/cls/r/new-bo…
1
3
16
5,857
CLS restructures to focus entirely on its successful neurosurgery business. A sharper focus paves the way for sustainable growth, value creation and innovation in medical technology. #neurosurgery #medtech #aktier $CLSB $CLPT news.cision.com/cls/r/cls-fo…
3
3
22
1,949
With today’s shift towards neurosurgery, CLS enhances its ability to scale and meet market demands. A stronger, more focused business moving forward at a time where the company experience tailwinds in the neurosurgery market.
1
3
211
With Peter Max and Peter Mantas at the helm, CLS is set for strategic growth and sharper execution. Their leadership will be pivotal in driving the company’s focused approach within the neurosurgery business, ensuring long-term success.
3
194